Correlation Between Spyre Therapeutics and 747262AW3

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and 747262AW3 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and 747262AW3 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and QVC 545 percent, you can compare the effects of market volatilities on Spyre Therapeutics and 747262AW3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of 747262AW3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and 747262AW3.

Diversification Opportunities for Spyre Therapeutics and 747262AW3

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Spyre and 747262AW3 is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and QVC 545 percent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on QVC 545 percent and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with 747262AW3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of QVC 545 percent has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and 747262AW3 go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and 747262AW3

Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 2.19 times more return on investment than 747262AW3. However, Spyre Therapeutics is 2.19 times more volatile than QVC 545 percent. It trades about 0.06 of its potential returns per unit of risk. QVC 545 percent is currently generating about 0.03 per unit of risk. If you would invest  1,498  in Spyre Therapeutics on September 12, 2024 and sell it today you would earn a total of  1,151  from holding Spyre Therapeutics or generate 76.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy96.02%
ValuesDaily Returns

Spyre Therapeutics  vs.  QVC 545 percent

 Performance 
       Timeline  
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Spyre Therapeutics is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
QVC 545 percent 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days QVC 545 percent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 747262AW3 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Spyre Therapeutics and 747262AW3 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spyre Therapeutics and 747262AW3

The main advantage of trading using opposite Spyre Therapeutics and 747262AW3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, 747262AW3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 747262AW3 will offset losses from the drop in 747262AW3's long position.
The idea behind Spyre Therapeutics and QVC 545 percent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments